title: New options for uveitis treatment.
abstract: Uveitis is one of the most important causes of blindness worldwide. Its etiology and pathogenesis are complicated and have not been well understood. The treatment for uveitis is predominantly based on steroids and immunosuppressants. However, systemic side effects limit their clinical application. With the advancement of molecular biology, some intravitreal implants and biologic agents have been used for the treatment of uveitis. Additionally, novel techniques such as gene therapy and RNA interference are being studied for using as uveitis therapy. This paper reviews recent advances in uveitis treatment.
authors.affiliation: Department of Ophthalmology, Fuling Center Hospital of Chongqing City, Chongqing 408000, China ; Department of Ophthalmology, the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China.
authors.forename: Yu
authors.initials: Y
authors.lastname: He
authors.forename: Song-Bai
authors.initials: SB
authors.lastname: Jia
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Jing-Ming
authors.initials: JM
authors.lastname: Shi
keywords: RNA interference; biologic agents; gene therapy; intravitreal implants; uveitis